ROYAL BANK OF CANADA - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$0
-100.0%
4
-99.9%
0.00%
Q1 2023$5,0007,318
+910.8%
0.00%
Q4 2022$0724
+2.4%
0.00%
Q3 2022$0707
+1437.0%
0.00%
Q2 2022$0
-100.0%
46
-99.5%
0.00%
Q1 2022$13,000
-69.8%
10,040
-70.5%
0.00%
Q4 2021$43,000
+30.3%
33,991
+129.4%
0.00%
Q3 2021$33,000
-17.5%
14,817
+39.9%
0.00%
Q2 2021$40,000
+100.0%
10,592
+76.4%
0.00%
Q1 2021$20,000
-83.2%
6,005
-82.8%
0.00%
Q4 2020$119,000
-36.7%
34,829
-24.3%
0.00%
Q3 2020$188,000
+56.7%
45,993
+30.0%
0.00%
Q2 2020$120,000
+21.2%
35,389
-16.8%
0.00%
Q1 2020$99,000
+125.0%
42,516
+245.7%
0.00%
Q4 2019$44,000
+131.6%
12,299
+434.7%
0.00%
Q3 2019$19,000
-5.0%
2,300
-0.8%
0.00%
Q2 2019$20,000
-73.0%
2,319
-66.4%
0.00%
Q1 2019$74,000
+270.0%
6,902
+200.1%
0.00%
Q4 2018$20,000
-96.8%
2,300
-93.8%
0.00%
Q3 2018$621,000
-12.9%
36,975
+8.6%
0.00%
Q2 2018$713,000
+222.6%
34,041
+147.7%
0.00%
Q1 2018$221,000
-18.8%
13,741
-4.2%
0.00%
Q4 2017$272,000
-98.2%
14,341
-98.7%
0.00%
-100.0%
Q3 2017$15,387,000
+202.8%
1,093,544
+60.3%
0.01%
+133.3%
Q2 2017$5,082,000
+9.3%
682,114
-4.6%
0.00%0.0%
Q1 2017$4,649,000
+47.4%
715,251
+0.5%
0.00%
+50.0%
Q4 2016$3,153,000
-21.4%
711,835
-17.1%
0.00%0.0%
Q3 2016$4,011,000
-37.1%
858,898
-11.5%
0.00%
-50.0%
Q2 2016$6,375,000
-0.5%
970,332
-3.7%
0.00%0.0%
Q1 2016$6,410,000
+1.4%
1,007,904
-3.9%
0.00%0.0%
Q4 2015$6,324,000
+3.8%
1,048,807
+3.0%
0.00%
-20.0%
Q3 2015$6,090,000
-12.7%
1,018,331
-0.2%
0.01%0.0%
Q2 2015$6,978,000
+13.2%
1,020,207
+0.4%
0.01%
+25.0%
Q1 2015$6,166,000
-13.7%
1,015,848
-1.5%
0.00%
-20.0%
Q4 2014$7,144,000
-12.6%
1,030,882
+2.7%
0.01%
-16.7%
Q3 2014$8,174,000
-3.5%
1,004,207
-3.6%
0.01%0.0%
Q2 2014$8,473,000
+5.9%
1,042,118
+2.1%
0.01%0.0%
Q1 2014$8,000,000
-22.9%
1,020,425
-13.0%
0.01%
-14.3%
Q4 2013$10,381,000
+11970.9%
1,173,057
+11280.1%
0.01%
Q3 2013$86,000
-7.5%
10,308
-17.6%
0.00%
Q2 2013$93,00012,5080.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders